Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.10)
# 3,534
Out of 4,732 analysts
262
Total ratings
28.94%
Success rate
-16.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Reiterates: Sell | $75 | $118.00 | -36.44% | 4 | Jan 15, 2025 | |
| RLYB Rallybio | Reiterates: Buy | $5 | $0.88 | +471.30% | 17 | Jan 13, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $16.19 | +85.30% | 17 | Jan 13, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $68 → $70 | $54.80 | +27.74% | 31 | Jan 10, 2025 | |
| CTMX CytomX Therapeutics | Reiterates: Neutral | n/a | $0.84 | - | 7 | Jan 7, 2025 | |
| ALMS Alumis | Reiterates: Buy | $26 | $7.66 | +239.43% | 4 | Jan 6, 2025 | |
| ZURA Zura Bio | Reiterates: Neutral | $5 | $1.77 | +182.49% | 5 | Dec 24, 2024 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $12.25 | +267.35% | 4 | Dec 20, 2024 | |
| CARM Carisma Therapeutics | Downgrades: Neutral | n/a | $0.44 | - | 12 | Dec 16, 2024 | |
| LEGN Legend Biotech | Reiterates: Buy | $73 | $32.66 | +123.52% | 32 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $14 | $2.61 | +436.40% | 8 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.6 → $2.4 | $0.38 | +533.25% | 3 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 → $45 | $19.29 | +133.28% | 14 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $16.60 | +231.33% | 13 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $37.00 | +210.81% | 10 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.33 | +80.18% | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.31 | +587.02% | 14 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 | $19.03 | +131.21% | 11 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $20.97 | +424.56% | 13 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $23 | $5.07 | +353.65% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $1 | $0.58 | +73.76% | 10 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $6.14 | +128.01% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $0.91 | +449.87% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $2,440 | $0.13 | +1,855,413.31% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.12 | - | 4 | Jun 2, 2023 |
Sarepta Therapeutics
Jan 15, 2025
Reiterates: Sell
Price Target: $75
Current: $118.00
Upside: -36.44%
Rallybio
Jan 13, 2025
Reiterates: Buy
Price Target: $5
Current: $0.88
Upside: +471.30%
Tyra Biosciences
Jan 13, 2025
Reiterates: Buy
Price Target: $30
Current: $16.19
Upside: +85.30%
Halozyme Therapeutics
Jan 10, 2025
Maintains: Buy
Price Target: $68 → $70
Current: $54.80
Upside: +27.74%
CytomX Therapeutics
Jan 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.84
Upside: -
Alumis
Jan 6, 2025
Reiterates: Buy
Price Target: $26
Current: $7.66
Upside: +239.43%
Zura Bio
Dec 24, 2024
Reiterates: Neutral
Price Target: $5
Current: $1.77
Upside: +182.49%
Oruka Therapeutics
Dec 20, 2024
Reiterates: Buy
Price Target: $45
Current: $12.25
Upside: +267.35%
Carisma Therapeutics
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.44
Upside: -
Legend Biotech
Dec 10, 2024
Reiterates: Buy
Price Target: $73
Current: $32.66
Upside: +123.52%
Dec 10, 2024
Maintains: Buy
Price Target: $7 → $14
Current: $2.61
Upside: +436.40%
Dec 6, 2024
Maintains: Buy
Price Target: $5.6 → $2.4
Current: $0.38
Upside: +533.25%
Dec 4, 2024
Reiterates: Buy
Price Target: $41 → $45
Current: $19.29
Upside: +133.28%
Nov 25, 2024
Reiterates: Buy
Price Target: $55
Current: $16.60
Upside: +231.33%
Nov 22, 2024
Reiterates: Buy
Price Target: $115
Current: $37.00
Upside: +210.81%
Nov 20, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.33
Upside: +80.18%
Nov 19, 2024
Reiterates: Buy
Price Target: $9
Current: $1.31
Upside: +587.02%
Nov 18, 2024
Reiterates: Buy
Price Target: $44
Current: $19.03
Upside: +131.21%
Nov 18, 2024
Reiterates: Buy
Price Target: $110
Current: $20.97
Upside: +424.56%
Nov 14, 2024
Maintains: Buy
Price Target: $21 → $23
Current: $5.07
Upside: +353.65%
Nov 12, 2024
Reiterates: Neutral
Price Target: $1
Current: $0.58
Upside: +73.76%
Nov 6, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $6.14
Upside: +128.01%
Nov 6, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $0.91
Upside: +449.87%
Sep 6, 2023
Maintains: Buy
Price Target: $160 → $2,440
Current: $0.13
Upside: +1,855,413.31%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $4.12
Upside: -